163 related articles for article (PubMed ID: 24023308)
1. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer.
Lee KH; Hwang D; Kang KY; Lee S; Kim DY; Joo YE; Lee JH
Anticancer Res; 2013 Sep; 33(9):3765-74. PubMed ID: 24023308
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
[TBL] [Abstract][Full Text] [Related]
3. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
[TBL] [Abstract][Full Text] [Related]
4. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
5. The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer.
Concolino P; Papa V; Mozzetti S; Ferlini C; Pacelli F; Martinelli E; Ricci R; Filippetti F; Scambia G; Doglietto GB
J Surg Res; 2004 Sep; 121(1):50-5. PubMed ID: 15313375
[TBL] [Abstract][Full Text] [Related]
6. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil.
Borges Bdo N; Santos Eda S; Bastos CE; Pinto LC; Anselmo NP; Quaresma JA; Calcagno DQ; Burbano RM; Harada ML
Anticancer Res; 2010 Jun; 30(6):2225-33. PubMed ID: 20651373
[TBL] [Abstract][Full Text] [Related]
7. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA methylation in the development of diffuse-type gastric cancer.
Yamamoto E; Suzuki H; Takamaru H; Yamamoto H; Toyota M; Shinomura Y
Digestion; 2011; 83(4):241-9. PubMed ID: 21273772
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
[TBL] [Abstract][Full Text] [Related]
10. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
11. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.
Grady WM; Willis J; Guilford PJ; Dunbier AK; Toro TT; Lynch H; Wiesner G; Ferguson K; Eng C; Park JG; Kim SJ; Markowitz S
Nat Genet; 2000 Sep; 26(1):16-7. PubMed ID: 10973239
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
14. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
[TBL] [Abstract][Full Text] [Related]
15. [Promoter methylation profile in gastric cancer].
Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
[TBL] [Abstract][Full Text] [Related]
16. [E-cadherin expression and CDH1 promoter methylation in sporadic and hereditary gastric cancer].
Li XJ; Zhao Y; Ren H
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):125-7. PubMed ID: 25613626
[TBL] [Abstract][Full Text] [Related]
17. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
18. [E-cadherin expression and CDH1 promoter methylation in sporadic and hereditary gastric cancer].
Li XJ; Zhao Y; Ren H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):125-7. PubMed ID: 23353171
[TBL] [Abstract][Full Text] [Related]
19. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients.
Muretto P; Ruzzo A; Pizzagalli F; Graziano F; Maltese P; Zingaretti C; Berselli E; Donnarumma N; Magnani M
Ann Oncol; 2008 Mar; 19(3):516-9. PubMed ID: 17986624
[TBL] [Abstract][Full Text] [Related]
20. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
